EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients

Carol D SanMartín, Felipe Salech, Daniela Paz Ponce, Jorge Concha-Cerda iD, Esteban Romero-Hernández iD, Gianella Liabeuf iD, Nicole K Rogers, Paola Murgas iD, Bárbara Bruna iD, Jamileth More iD, María I Behrens iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24087364 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Carol D SanMartín und 10 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación Clínica Avanzada (CICA), Facultad de Medicina-Hospital Clínico, Universidad de Chile, Independencia, Santiago 8380453, Chile. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Neoplasms. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agencia Nacional de Investigación y Desarrollo, U-Redes Universidad de Chile, Agencia Nacional de Investigación y Desarrollo de Chile (ANID) FONDECYT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Epidemiological studies show that having a history of cancer protects from the development of Alzheimer’s Disease (AD), and vice versa, AD protects from cancer. The mechanism of this mutual protection is unknown. We have reported that the peripheral blood mononuclear cells (PBMC) of amnestic cognitive impairment (aMCI) and Alzheimer’s Disease (AD) patients have increased susceptibility to oxidative cell death compared to control subjects, and from the opposite standpoint a cancer history is associated with increased resistance to oxidative stress cell death in PBMCs, even in those subjects who have cancer history and aMCI (Ca + aMCI). Cellular senescence is a regulator of susceptibility to cell death and has been related to the pathophysiology of AD and cancer. Recently, we showed that cellular senescence markers can be tracked in PBMCs of aMCI patients, so we here investigated whether these senescence markers are dependent on having a history of cancer. Senescence-associated βeta-galactosidase (SA-β-Gal) activity, G0-G1 phase cell-cycle arrest, p16 and p53 were analyzed by flow cytometry; phosphorylated H2A histone family member X (γH2AX) by immunofluorescence; IL-6 and IL-8 mRNA by qPCR; and plasmatic levels by ELISA. Senescence markers that were elevated in PBMCs of aMCI patients, such as SA-β-Gal, Go-G1 arrested cells, IL-6 and IL-8 mRNA expression, and IL-8 plasmatic levels, were decreased in PBMCs of Ca + aMCI patients to levels similar to those of controls or of cancer survivors without cognitive impairment, suggesting that cancer in the past leaves a fingerprint that can be peripherally traceable in PBMC samples. These results support the hypothesis that the senescence process might be involved in the inverse association between cancer and AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionNeoplasmsHumansLeukocytes, MononuclearInterleukin-6Interleukin-8Neuropsychological TestsCognitionRNA, Messenger

Stichwörter der Autor:innen

Alzheimer’s Disease (AD)agingamnestic mild cognitive impairment (aMCI)cancer historycellular senescenceperipheral blood mononuclear cells (PBMCs)

Substanzen

Interleukin-6Interleukin-8RNA, Messenger

Autor:innen und Institutionen

  • Centro de Investigación Clínica Avanzada (CICA), Facultad de Medicina-Hospital Clínico, Universidad de Chile, Independencia, Santiago 8380453, Chile.
  • Departamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Independencia, Santiago 8380430, Chile.
  • Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas (ICBM), Facultad de Medicina, Universidad de Chile, Santiago 8380453, Chile.
  • Laboratorio de Obesidad y Metabolismo Energético (OMEGA), Instituto de Nutrición y Tecnología de los Alimentos (INTA), Universidad de Chile, Santiago 7830490, Chile.
  • Departamento de Neurociencia, Facultad de Medicina, Universidad de Chile, Independencia, Santiago 8380453, Chile.
  • Instituto de Bioquímica y Microbiología, Facultad de Ciencias, Universidad Austral de Chile, Valdivia 5110566, Chile.

ORCID-Profile: Jorge Concha-Cerda, Esteban Romero-Hernández, Gianella Liabeuf, Paola Murgas, Bárbara Bruna, Jamileth More, María I Behrens

Förderung

  • Agencia Nacional de Investigación y Desarrollo
  • U-Redes Universidad de Chile
  • Agencia Nacional de Investigación y Desarrollo de Chile (ANID) FONDECYT
  • al de Investigación y Desarrollo de Chile (ANID) Fondecyt Postdoctorado
  • Agencia Nacional de Investigación y Desarrollo de Chile (ANID) Beca de Doctorado Nacional Folio
  • Agencia Nacional de Investigación y Desarrollo de Chile (ANID) FONDEF

Zitieren

APA

SanMartín, C. D., Salech, F., Ponce, D. P., Concha-Cerda, J., Romero-Hernández, E., Liabeuf, G., Rogers, N. K., Murgas, P., Bruna, B., More, J., & Behrens, M. I. (2023). Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24087364

Vancouver

SanMartín CD, Salech F, Ponce DP, Concha-Cerda J, Romero-Hernández E, Liabeuf G, et al. Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24087364

BibTeX
@article{SanMartn2023,
  author = {SanMartín, Carol D and Salech, Felipe and Ponce, Daniela Paz and Concha-Cerda, Jorge and Romero-Hernández, Esteban and Liabeuf, Gianella and Rogers, Nicole K and Murgas, Paola and Bruna, Bárbara and More, Jamileth and Behrens, María I},
  title = {Cancer History Avoids the Increase of Senescence Markers in Peripheral Cells of Amnestic Mild Cognitive Impaired Patients},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24087364}
}
Kostenlos starten →